RMC-7977, a highly selective inhibitor of the active RAS-GTP to treat pancreatic cancer

Acta Pharm Sin B. 2024 Oct;14(10):4622-4624. doi: 10.1016/j.apsb.2024.07.014. Epub 2024 Jul 20.
No abstract available

Keywords: Inhibitor; Pancreatic cancer; RAS-GTP; RMC-7977.